We are live on ! Find out more
TECH icon

Bio-Techne

297 hedge funds and large institutions have $4.72B invested in Bio-Techne in 2017 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 105 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

6% more capital invested

Capital invested by funds: $4.46B → $4.72B (+$256M)

2% more funds holding

Funds holding: 292297 (+5)

6% less repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 105

6.02% less ownership

Funds ownership: 394.86%388.84% (-6%)

19% less call options, than puts

Call options by funds: $557K | Put options by funds: $687K

Holders
297
Holders Change
+5
Holders Change %
+1.71%
% of All Funds
6.74%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
41
Increased
99
Reduced
105
Closed
35
Calls
$557K
Puts
$687K
Net Calls
-$130K
Net Calls Change
-$94K
Name Holding Trade Value Shares
Change
Change in
Stake
Assenagon Asset Management
301
Assenagon Asset Management
Luxembourg
-$3.57M -117,988 Closed
GAM
302
Gotham Asset Management
New York
-$3.18M -105,220 Closed
SGH
303
Sivik Global Healthcare
Connecticut
-$2.58M -85,356 Closed
AP
304
AHL Partners
United Kingdom
-$2.05M -67,940 Closed
MWNA
305
Marshall Wace North America
New York
-$2.05M -67,628 Closed
FAM
306
Formidable Asset Management
Ohio
-$1.03M -34,196 Closed
DTL
307
Dynamic Technology Lab
Singapore
-$887K -29,356 Closed
WA
308
Wasatch Advisors
Utah
-$867K -28,676 Closed
Two Sigma Investments
309
Two Sigma Investments
New York
-$863K -28,540 Closed
Two Sigma Advisers
310
Two Sigma Advisers
New York
-$704K -23,300 Closed
PP
311
Paloma Partners
Connecticut
-$670K -22,184 Closed
Verition Fund Management
312
Verition Fund Management
Connecticut
-$620K -20,516 Closed
Fidelity Investments
313
Fidelity Investments
Massachusetts
-$568K -18,800 Closed
TA
314
Tiedemann Advisors
New York
-$447K -16,312 Closed
JG
315
Jefferies Group
New York
-$486K -16,076 Closed
BCM
316
BlueCrest Capital Management
Jersey
-$473K -15,660 Closed
KI
317
Koch Industries
Kansas
-$399K -13,172 Closed
CSS
318
Cubist Systematic Strategies
Connecticut
-$390K -12,904 Closed
PM
319
Parametrica Management
Hong Kong
-$383K -12,664 Closed
HCMT
320
Highland Capital Management (Texas)
Texas
-$363K -12,000 Closed
GCP
321
GSA Capital Partners
United Kingdom
-$351K -11,600 Closed
AP
322
Advisors Preferred
Maryland
-$318K -10,536 Closed
PCM
323
Prelude Capital Management
New York
-$312K -10,320 Closed
TI
324
Turner Investments
Pennsylvania
-$242K -8,000 Closed
BA
325
Bridgewater Associates
Connecticut
-$236K -7,820 Closed

TECH Hedge Fund Activity: Q4 2017 in Review

297 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2017, worth a combined $4.72B — up 5.7% from $4.46B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new TECH positions and 35 closed out — a net gain of 6 holders — while 99 added to existing stakes and 105 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $44.2M. The largest seller was Select Equity Group, cutting an estimated $47M.

  • 297 institutional investors held Bio-Techne (TECH) as of Q4 2017, up from 292 in Q3 2017.
  • Funds reported $4.72B of Bio-Techne stock for Q4 2017, up 5.7% quarter-over-quarter.
  • 41 funds opened new Bio-Techne positions in Q4 2017 and 35 closed out, a net change of +6 holders.
  • The largest Bio-Techne buyer in Q4 2017 was TimesSquare Capital Management, an estimated $44.2M added.
  • The largest Bio-Techne seller in Q4 2017 was Select Equity Group, an estimated $47M sold.

Based on aggregated 13F filings for Q4 2017.